2026 RNDS | Q-Cell Study Updates @wearesrna
2026 RNDS | Q-Cell Study Updates  @wearesrna
Uploaded October 2026 | Updated November 2026, 3 hours ago
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Benjamin Greenberg, MD, MHS, of the University of Texas Southwestern gave an update on the Q-Cell stem cell study in myelitis [00:00:06]. He explained how stem cells could repair myelin in the spinal cord, along with the risks that took years of animal studies to address, including cells forming something unwanted and the body rejecting them [00:00:59]. He warned about unregulated stem cell clinics and described why Q-Cells were chosen and how a floating cannula delivers them into the spinal cord [00:06:44]. Dr. Greenberg reviewed who can take part, the safety findings so far in the people who have had the procedure, and how to sign up through the SRNA website [00:15:37]. He ended with thanks to donors, the surgical team, and participants, then took audience questions about next steps, including enrolling people with recurrences and treating the neck [00:21:17].

Benjamin Greenberg, MD, MHS, received his Bachelor of Arts degree from Johns Hopkins University and his Master's degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health. He attended medical school at Baylor College of Medicine, completed his neurology residency at The Johns Hopkins Hospital, and joined the Hopkins faculty in neuroimmunology, where he became Co-Director of the Transverse Myelitis Center and Director of the Encephalitis Center. In 2009, he was recruited to the University of Texas Southwestern Medical Center as Director of the new Transverse Myelitis and Neuromyelitis Optica Program, and that same year he established the Pediatric Demyelinating Disease Program at Children's Medical Center Dallas.

He now serves as Director of the Perot Foundation Neurosciences Translational Research Center within the O'Donnell Brain Institute and Vice Chair of Translational Research for the Department of Neurology. Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system.

00:00 Welcome and Introduction
00:39 Disclosures
00:59 The Promise of Stem Cells
03:27 Risks of Stem Cell Transplants
06:44 Unregulated Stem Cell Clinics
08:43 Why Q-Cells Were Chosen
11:22 Getting Cells to the Spinal Cord
15:37 Who Can Take Part
18:16 Safety Results So Far
19:51 How to Sign Up and Next Steps
21:17 Acknowledgements
23:17 Questions from the Audience
2026 RNDS | Q-Cell Study Updates2026 RNDS | Spasticity Management and Mobility2025 RNDS en Español | Panel de aliados de la industria con Genentech1203. Community Spotlight | Rick TelanderCommunity Meets Clinic 303. Dr. Benjamin Greenberg2025 RNDS | Cognition, depression; psychological impacts and rare neuroimmune disorders1310.  Prevention and Treatment of Skin Breakdown2026 RNDS | Infection-Related Myelitis2024 RNDS | Clinical Analysis of Children Presenting with ADEM with or without MOG-IgG501. Transitioning from Pediatric to Adult Care with NMOSD103. Dr. Jennifer Graves2025 RNDS en Español | Panel de aliados de la industria con UCB
SRNA |

2026 RNDS | Q-Cell Study Updates

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER